Clinical Trials · Pharmacology

Which phase of clinical testing is often skipped or shortened for 'Breakthrough Therapies' for life-threatening conditions?

  1. Preclinical
  2. Phase I
  3. Phase III
  4. Phase IV
Show answer and explanation

Correct answer: Phase III

Under certain expedited pathways, the FDA may grant accelerated approval based on Phase II surrogate endpoints. This allows patients with serious diseases earlier access to drugs while larger Phase III trials are still ongoing.

Difficulty: Medium Question 17 of 20

Practice all 20 Clinical Trials questions

Keep practicing

More Clinical Trials questions